CRINETICS PHARMACEUTICALS IN filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by CRINETICS PHARMACEUTICALS IN (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2024-03-11EcoR1 Capital, LLCCrinetics Pharmaceuticals, Inc.4,155,3755.3%EDGAR
SC 13D/A2024-03-01PERCEPTIVE ADVISORS LLCCrinetics Pharmaceuticals, Inc.1,488,7031.9%EDGAR
SC 13G/A2024-02-14Point72 Asset Management, L.P.Crinetics Pharmaceuticals, Inc.3,416,9005.1%EDGAR
SC 13G/A2024-02-14BIOTECHNOLOGY VALUE FUND L PCrinetics Pharmaceuticals, Inc.00.0%EDGAR
SC 13G/A2024-02-14DRIEHAUS CAPITAL MANAGEMENT LLCCrinetics Pharmaceuticals, Inc.5,039,4777.5%EDGAR
SC 13G/A2024-02-14ORBIMED ADVISORS LLCCrinetics Pharmaceuticals, Inc.1,667,3602.5%EDGAR
SC 13G/A2024-02-14BRAIDWELL LPCrinetics Pharmaceuticals, Inc.00.0%EDGAR
SC 13G2024-02-13VANGUARD GROUP INCCrinetics Pharmaceuticals, Inc.3,502,4525.2%EDGAR
SC 13G2024-02-09FMR LLCCrinetics Pharmaceuticals, Inc.4,043,8656.1%EDGAR
SC 13G/A2024-02-08WELLINGTON MANAGEMENT GROUP LLPCrinetics Pharmaceuticals, Inc.3,245,1054.9%EDGAR
SC 13G/A2024-01-25BlackRock Inc.Crinetics Pharmaceuticals, Inc.5,345,1148.0%EDGAR
SC 13G2024-01-24STATE STREET CORPCrinetics Pharmaceuticals, Inc.-5.3%EDGAR
SC 13G2023-09-18Point72 Asset Management, L.P.Crinetics Pharmaceuticals, Inc.3,719,2005.6%EDGAR
SC 13G/A2023-02-14BIOTECHNOLOGY VALUE FUND L PCrinetics Pharmaceuticals, Inc.1,447,3172.7%EDGAR
SC 13G/A2023-02-14ORBIMED ADVISORS LLCCrinetics Pharmaceuticals, Inc.2,710,7105.0%EDGAR
SC 13G2023-02-14BRAIDWELL LPCrinetics Pharmaceuticals, Inc.3,469,6746.4%EDGAR
SC 13G/A2023-02-09FMR LLCCrinetics Pharmaceuticals, Inc.1,883,1183.5%EDGAR
SC 13G/A2023-02-08DRIEHAUS CAPITAL MANAGEMENT LLCCrinetics Pharmaceuticals, Inc.5,624,74410.4%EDGAR
SC 13G2023-02-06WELLINGTON MANAGEMENT GROUP LLPCrinetics Pharmaceuticals, Inc.2,804,4855.2%EDGAR
SC 13G/A2023-01-31BlackRock Inc.Crinetics Pharmaceuticals, Inc.3,917,4897.3%EDGAR
External links